Small bowel adenocarcinoma, version 1.2020

Al B. Benson; Alan P. Venook; Mahmoud M. Al-Hawary; Mustafa A. Arain; Yi Jen Chen; Kristen K. Ciombor; Stacey A. Cohen; Harry S. Cooper; Dustin A. Deming; Ignacio Garrido-Laguna; Jean L. Grem; Sarah E. Hoffe; Joleen Hubbard; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A. Messersmith; Jeffrey Meyerhardt; Eric D. Miller; Mary F. Mulcahy; Nurkin, Md, Ms Steven Nurkin, Md, Ms; Michael J. Overman; Aparna Parikh; Hitendra Patel; Katrina S. Pedersen; Leonard B. Saltz; Charles Schneider; David Shibata; John M. Skibber; Constantinos T. Sofocleous; Elena M. Stoffel; Eden Stotsky-Himelfarb; Christopher G. Willett; Alyse Johnson-Chilla; Kristina M. Gregory; Lisa A. Gurski

doi:10.6004/jnccn.2019.0043

Small bowel adenocarcinoma, version 1.2020

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido-Laguna, Jean L. Grem, Sarah E. Hoffe, Joleen Hubbard, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey Meyerhardt, Eric D. MillerMary F. Mulcahy, Nurkin, Md, Ms Steven Nurkin, Md, Ms, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Alyse Johnson-Chilla, Kristina M. Gregory, Lisa A. Gurski

Research output: Contribution to journal › Review article › peer-review

104 Scopus citations

Abstract

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.

Original language	English
Pages (from-to)	1109-1133
Number of pages	25
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2019.0043
State	Published - 2019

Access to Document

10.6004/jnccn.2019.0043

Cite this

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y. J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Garrido-Laguna, I., Grem, J. L., Hoffe, S. E., Hubbard, J., Hunt, S., Kamel, A., Kirilcuk, N., Krishnamurthi, S., Messersmith, W. A., Meyerhardt, J., ... Gurski, L. A. (2019). Small bowel adenocarcinoma, version 1.2020. JNCCN Journal of the National Comprehensive Cancer Network, 17(9), 1109-1133. https://doi.org/10.6004/jnccn.2019.0043

@article{a276cbd3f56f4f1e92d496fdcd33d093,

title = "Small bowel adenocarcinoma, version 1.2020",

abstract = "Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.",

author = "Benson, {Al B.} and Venook, {Alan P.} and Al-Hawary, {Mahmoud M.} and Arain, {Mustafa A.} and Chen, {Yi Jen} and Ciombor, {Kristen K.} and Cohen, {Stacey A.} and Cooper, {Harry S.} and Deming, {Dustin A.} and Ignacio Garrido-Laguna and Grem, {Jean L.} and Hoffe, {Sarah E.} and Joleen Hubbard and Steven Hunt and Ahmed Kamel and Natalie Kirilcuk and Smitha Krishnamurthi and Messersmith, {Wells A.} and Jeffrey Meyerhardt and Miller, {Eric D.} and Mulcahy, {Mary F.} and {Steven Nurkin, Md, Ms}, {Nurkin, Md, Ms} and Overman, {Michael J.} and Aparna Parikh and Hitendra Patel and Pedersen, {Katrina S.} and Saltz, {Leonard B.} and Charles Schneider and David Shibata and Skibber, {John M.} and Sofocleous, {Constantinos T.} and Stoffel, {Elena M.} and Eden Stotsky-Himelfarb and Willett, {Christopher G.} and Alyse Johnson-Chilla and Gregory, {Kristina M.} and Gurski, {Lisa A.}",

year = "2019",

doi = "10.6004/jnccn.2019.0043",

language = "English",

volume = "17",

pages = "1109--1133",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "9",

}

Benson, AB, Venook, AP, Al-Hawary, MM, Arain, MA, Chen, YJ, Ciombor, KK, Cohen, SA, Cooper, HS, Deming, DA, Garrido-Laguna, I, Grem, JL, Hoffe, SE, Hubbard, J, Hunt, S, Kamel, A, Kirilcuk, N, Krishnamurthi, S, Messersmith, WA, Meyerhardt, J, Miller, ED, Mulcahy, MF, Steven Nurkin, Md, Ms, NMM, Overman, MJ, Parikh, A, Patel, H, Pedersen, KS, Saltz, LB, Schneider, C, Shibata, D, Skibber, JM, Sofocleous, CT, Stoffel, EM, Stotsky-Himelfarb, E, Willett, CG, Johnson-Chilla, A, Gregory, KM & Gurski, LA 2019, 'Small bowel adenocarcinoma, version 1.2020', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 9, pp. 1109-1133. https://doi.org/10.6004/jnccn.2019.0043

TY - JOUR

T1 - Small bowel adenocarcinoma, version 1.2020

AU - Benson, Al B.

AU - Venook, Alan P.

AU - Al-Hawary, Mahmoud M.

AU - Arain, Mustafa A.

AU - Chen, Yi Jen

AU - Ciombor, Kristen K.

AU - Cohen, Stacey A.

AU - Cooper, Harry S.

AU - Deming, Dustin A.

AU - Garrido-Laguna, Ignacio

AU - Grem, Jean L.

AU - Hoffe, Sarah E.

AU - Hubbard, Joleen

AU - Hunt, Steven

AU - Kamel, Ahmed

AU - Kirilcuk, Natalie

AU - Krishnamurthi, Smitha

AU - Messersmith, Wells A.

AU - Meyerhardt, Jeffrey

AU - Miller, Eric D.

AU - Mulcahy, Mary F.

AU - Steven Nurkin, Md, Ms, Nurkin, Md, Ms

AU - Overman, Michael J.

AU - Parikh, Aparna

AU - Patel, Hitendra

AU - Pedersen, Katrina S.

AU - Saltz, Leonard B.

AU - Schneider, Charles

AU - Shibata, David

AU - Skibber, John M.

AU - Sofocleous, Constantinos T.

AU - Stoffel, Elena M.

AU - Stotsky-Himelfarb, Eden

AU - Willett, Christopher G.

AU - Johnson-Chilla, Alyse

AU - Gregory, Kristina M.

AU - Gurski, Lisa A.

PY - 2019

Y1 - 2019

N2 - Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.

AB - Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.

UR - http://www.scopus.com/inward/record.url?scp=85071741274&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0043

DO - 10.6004/jnccn.2019.0043

M3 - Review article

C2 - 31487687

AN - SCOPUS:85071741274

SN - 1540-1405

VL - 17

SP - 1109

EP - 1133

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Small bowel adenocarcinoma, version 1.2020

Abstract

Access to Document

Other files and links

Fingerprint

Cite this